Genmed was founded in 2007 by Robin Modak with a little help from Peter Staff and Keith Davis. From the start it was clear that there wasn’t an easy way to recruit ‘Genmed people’! The blend of skills and experience required was not obvious. A passion for providing customer service excellence? The desire and drive to succeed? A winning mentality? Despite the difficulty we have assembled a team of more than 50 ‘Genmed people’ who are committed to delivering service excellence and who strive to succeed every day.
Robin Modak is the founder and chairman of Genmed having launched the company in 2007. Prior to launching Genmed, Robin had a variety of roles in large corporate organisations in London such as GE Healthcare and Rothschild Bank (Five Arrows Leasing Group), which gave a solid foundation to the organisation he has since built. Robin is passionate about providing new ways to use and combine resources to bring innovative support to NHS Healthcare. Robin officially moved into the position of Chairman in October 2019 having spent 12 years as Chief Executive.
Jonathan joined Genmed as the Chairman in August 2018 before transitioning to the position of Chief Executive in October 2019 and has brought a rich background in Healthcare and Procurement to the role. Jonathan has worked in the past as Commercial Director for West Midlands Health Authority, Chief Executive of Healthcare Purchasing Consortium and also Chief Executive of HealthTrust Europe.
Ruth started her career at PwC in Bristol specialising in the aerospace and defence sector before joining a client after a major acquisition. In 2012 she joined a private equity backed IT Managed Service Provider called Adapt, based in Cardiff and after 2 successful private equity sale processes, she joined Genmed in early 2019. Ruth is passionate about customer service, automation and process improvement to allow our staff to add real value and make a difference.
A founding director of Genmed, Keith joined full-time as Chief Operating Officer 2011 and became Chief Commercial Officer in April 2020. Prior to joining Genmed, Keith managed a UK distributor of flexible endoscopes which was acquired by a major Irish medical group, as well as spending a year managing their surgical robot business. First entering the medical devices sector in 1992 he spent a number of years in commercial and manufacturing roles with Seward Medical, a manufacturer and distributor of a diverse range of medical devices.
Peter Staff was the Chairman and CEO of Xograph Group for nearly 20 years and was with the company for over 45 years. Xograph Healthcare is a specialist independent provider of medical imaging systems to the healthcare sector with employees in UK and Republic of Ireland.
Staff served two terms as a member of the Associate Parliamentary Health Group. He has a special interest in medical equipment and device issues. He sat on the Department of Health’s NHS Supply Chain Supplier Board, is also a past Chairman of AXREM, the Association of X-Ray Equipment Manufacturers and is an honorary life member of the British Institute of Radiology.
Under his guidance, Xograph Healthcare won awards from the DTI and Deputy Prime Minister for innovation, export and customer care, as well as gaining several large long-term contracts from the Ministry of Defence, Home Office and Heathrow and Gatwick Airports. Xograph Healthcare and Xograph Ireland were recently purchased by HC21 - an Irish Healthcare Group.
As well as a Director of Xograph Ireland, he was also Chairman of Xograph Technologies, a leading British designer and manufacturer of innovative healthcare and scientific products. He has worked with The Genmed Group for the last 10 years where he can make use of his 45+ years’ experience in healthcare and his wide connections in business and government.
Geoff Baker joined the Board of Genmed in 2018. Geoff is Chartered Engineer with a distinguished international business career having established several successful business. He holds several non-executive positions and is an active advisor with Southampton University’s Business Accelerator and gives occasional guest lectures on their Management and MBA courses. He is recent Past President of the Institution of Mechanical Engineers and a Fellow of the Institution of Engineering and Technology.
Marie Forkan joined Genmed in January 2020 as its first General Counsel and is a solicitor by profession. She oversees all legal activity at Genmed. Prior to Genmed, Marie was Head of Legal for Spire Healthcare Group plc and a finance lawyer at international law firm Freshfields Bruckhaus Deringer.
One of the original members of the Genmed team joining in 2013, Jolene became Operations Director in April 2020. She has filled a number of roles since being in Genmed, gaining experience across managed services and works closely with suppliers and clinical teams to ensure a true partnership for the best results.
Sandeep first joined Genmed in 2012 and has had a number of roles within the organisation, before taking responsibility for Business Development, Marketing and Bids & Tenders. Sandeep has previously worked in laboratory diagnostics within the NHS and forensics sector, but also has experience working within a worldwide US genetic testing and diagnostics company where she was responsible for growth within the UK and Ireland business. Sandeep also currently sits on the Board of BIVDA (British In Vitro Diagnostics Association).
Peter has had an extensive career in all areas of procurement and supply chain in both the public and private sectors. His experience includes procurement roles in organisations such as The Unipart Group and Rolls-Royce as well as ten years in the NHS. Peter leads all procurement activity across the company including our procurement services division. A Member of the Chartered Institute of Purchasing, Peter also holds a Masters Degree from the Warwick University Business School.
Andrew Gore joined the Board of Genmed in January 2021. Andrew brings a wealth of healthcare experience to Genmed gained over a 25-year career in senior executive leadership roles within the private acute healthcare sector in the UK and Ireland. Andrew has always focused on leading businesses in a balanced way ensuring there is an equal balance between clinical quality, patient safety and commercial performance.
Most recently Andrew was CEO of St Vincent’s Private Hospital, the largest private acute hospital in Dublin specialising in the treatment of all aspects of cancer care. Prior to that he ran his own healthcare consultancy providing support to clients in developing their businesses whilst focusing on delivering high quality patient care.
Andrew has also been COO of Spire Healthcare and HCA Healthcare UK. Whilst at Spire Healthcare, the UK’s only listed private healthcare provider, he was part of the executive team that successfully led the business through to listing on the London Stock Exchange.